{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T02:02:26Z","timestamp":1788746546689,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011665","name":"Deanship of Scientific Research, King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007414","name":"Qassim University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Structure"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.molstruc.2021.131124","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T20:26:15Z","timestamp":1626553575000},"page":"131124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Targeting SARS-CoV-2 main protease by teicoplanin: A mechanistic insight by docking, MM\/GBSA and molecular dynamics simulation"],"prefix":"10.1016","volume":"1246","author":[{"given":"Faizul","family":"Azam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eltayeb E M","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkarim","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molstruc.2021.131124_bib0001","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health \u2014 the latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.molstruc.2021.131124_bib0002","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.molstruc.2021.131124_bib0003","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.7150\/ijbs.45053","article-title":"SARS-CoV-2: an emerging coronavirus that causes a global threat","volume":"16","author":"Zheng","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.molstruc.2021.131124_bib0004","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ije\/dyaa033","article-title":"The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?","volume":"49","author":"Peeri","year":"2020","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.molstruc.2021.131124_bib0005","doi-asserted-by":"crossref","DOI":"10.1097\/JCMA.0000000000000463","article-title":"Clinical manifestation and disease progression in COVID-19 infection","volume":"84","author":"Tsai","year":"2021","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.molstruc.2021.131124_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105937","article-title":"COVID-19 therapeutic and prevention","volume":"55","author":"Raoult","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.molstruc.2021.131124_bib0007","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3389\/fmicb.2020.01723","article-title":"Therapeutic strategies against COVID-19 and structural characterization of SARS-CoV-2: a review","volume":"11","author":"Jeong","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.molstruc.2021.131124_bib0008","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.molstruc.2021.131124_bib0009","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molstruc.2021.131124_bib0010","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1021\/acsmedchemlett.0c00521","article-title":"Identification of 14 Known drugs as inhibitors of the main protease of SARS-CoV-2","volume":"11","author":"Ghahremanpour","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.molstruc.2021.131124_bib0011","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/d41587-020-00003-1","article-title":"Coronavirus puts drug repurposing on the fast track","volume":"38","author":"Harrison","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molstruc.2021.131124_bib0012","doi-asserted-by":"crossref","first-page":"9218","DOI":"10.1074\/jbc.M116.716100","article-title":"Glycopeptide antibiotics potently inhibit cathepsin L in the late endosome\/lysosome and block the entry of Ebola virus, middle east respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV)","volume":"291","author":"Zhou","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molstruc.2021.131124_bib0013","article-title":"Teicoplanin potently blocks the cell entry of 2019-nCoV","author":"Zhang","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.molstruc.2021.131124_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105944","article-title":"Teicoplanin: an alternative drug for the treatment of COVID-19?","volume":"55","author":"Baron","year":"2020","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.1016\/j.molstruc.2021.131124_bib0015","article-title":"Structure-based design, synthesis, molecular docking, and biological activities of 2-(3-benzoylphenyl) propanoic acid derivatives as dual mechanism drugs","volume":"4","author":"Ahmed","year":"2012","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.molstruc.2021.131124_bib0016","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/0954898X.2016.1146416","article-title":"Molecular interaction studies of green tea catechins as multitarget drug candidates for the treatment of Parkinson's disease: computational and structural insights","volume":"26","author":"Azam","year":"2015","journal-title":"Network"},{"key":"10.1016\/j.molstruc.2021.131124_bib0017","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1080\/07391102.2017.1338164","article-title":"NSAIDs as potential treatment option for preventing amyloid \u03b2 toxicity in Alzheimer's disease: an investigation by docking, molecular dynamics, and DFT studies","volume":"36","author":"Azam","year":"2018","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molstruc.2021.131124_bib0018","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1080\/08927022.2019.1662003","article-title":"Rutin as promising drug for the treatment of Parkinson's disease: an assessment of MAO-B inhibitory potential by docking, molecular dynamics and DFT studies","volume":"45","author":"Azam","year":"2019","journal-title":"Mol. Simul."},{"key":"10.1016\/j.molstruc.2021.131124_bib0019","article-title":"Oxasetin from lophiostoma sp. of the Baltic sea: identification, in silico binding mode prediction and antibacterial evaluation against fish pathogenic bacteria","volume":"8","author":"Shushni","year":"2013","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.molstruc.2021.131124_bib0020","first-page":"1057","article-title":"Structure-based design, synthesis and molecular modeling studies of thiazolyl urea derivatives as novel anti-parkinsonian agents","volume":"8","author":"Azam","year":"2012","journal-title":"Med. Chem."},{"key":"10.1016\/j.molstruc.2021.131124_bib0021","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-020-18096-2","article-title":"Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication","volume":"11","author":"Vuong","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molstruc.2021.131124_bib0022","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminform."},{"key":"10.1016\/j.molstruc.2021.131124_bib0023","series-title":"Schr\u00f6dinger Release 2020-3","year":"2020"},{"key":"10.1016\/j.molstruc.2021.131124_bib0024","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/qua.24481","article-title":"Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences","volume":"113","author":"Bochevarov","year":"2013","journal-title":"Int. J. Quantum Chem."},{"key":"10.1016\/j.molstruc.2021.131124_bib0025","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.molstruc.2021.131124_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201900511","article-title":"Breaking down the barriers to a natural antiviral agent: antiviral activity and molecular docking of erythrina speciosa extract, fractions, and the major compound","volume":"17","author":"Fahmy","year":"2020","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.molstruc.2021.131124_bib0027","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction","volume":"55","author":"Jacobson","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.molstruc.2021.131124_bib0028","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-2836(02)00470-9","article-title":"On the role of the crystal environment in determining protein side-chain conformations","volume":"320","author":"Jacobson","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.molstruc.2021.131124_bib0029","doi-asserted-by":"crossref","first-page":"S639","DOI":"10.4103\/0973-1296.139809","article-title":"Identification of natural inhibitors against angiotensin I converting enzyme for cardiac safety using induced fit docking and MM-GBSA studies","volume":"10","author":"Vijayakumar","year":"2014","journal-title":"Pharmacogn. Mag."},{"key":"10.1016\/j.molstruc.2021.131124_bib0030","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1021\/jm060522a","article-title":"Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring","volume":"49","author":"Lyne","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molstruc.2021.131124_bib0031","series-title":"Desmond Molecular Dynamics System","year":"2020"},{"key":"10.1016\/j.molstruc.2021.131124_bib0032","series-title":"Proceeding of the SC \u201906: Proceedings of the 2006 ACM\/IEEE conference on Supercomputing, IEEE","first-page":"43","article-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006"},{"key":"10.1016\/j.molstruc.2021.131124_bib0033","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.molstruc.2021.131124_bib0034","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","article-title":"Canonical dynamics: method for simulations in the canonical ensemble","volume":"31","author":"Hoover","year":"1985","journal-title":"Phys. Rev. A"},{"key":"10.1016\/j.molstruc.2021.131124_bib0035","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1063\/1.467468","article-title":"Constant pressure molecular dynamics algorithms","volume":"101","author":"Martyna","year":"1994","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.molstruc.2021.131124_bib0036","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1021\/j100078a035","article-title":"A multiple-time-step molecular dynamics algorithm for macromolecules","volume":"98","author":"Humphreys","year":"1994","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.molstruc.2021.131124_bib0037","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/08927029408022004","article-title":"A Comparison of particle-particle, particle-mesh and ewald methods for calculating electrostatic interactions in periodic molecular systems","volume":"14","author":"Luty","year":"1994","journal-title":"Mol. Simul."},{"key":"10.1016\/j.molstruc.2021.131124_bib0038","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1074\/jbc.272.2.701","article-title":"Additivity principles in biochemistry","volume":"272","author":"Dill","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molstruc.2021.131124_bib0039","doi-asserted-by":"crossref","DOI":"10.2174\/1570163813666160119092807","article-title":"Ester prodrugs of ketoprofen: synthesis, in vitro stability, in vivo biological evaluation and in silico comparative docking studies against COX-1 and COX-2","volume":"13","author":"Ahmed","year":"2016","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.molstruc.2021.131124_bib0040","doi-asserted-by":"crossref","DOI":"10.3109\/13880209.2015.1070877","article-title":"Anti-endotoxin effects of terpenoids fraction from hygrophila auriculata in lipopolysaccharide-induced septic shock in rats","volume":"54","author":"Hussain","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.molstruc.2021.131124_bib0041","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2147\/DDDT.S67778","article-title":"Ginger components as new leads for the design and development of novel multi-targeted anti-Alzheimer's drugs: a computational investigation","volume":"8","author":"Azam","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.molstruc.2021.131124_bib0042","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1021\/jm060207o","article-title":"Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease","volume":"49","author":"Lu","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molstruc.2021.131124_bib0043","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1371\/journal.pbio.0030324","article-title":"Design of wide-spectrum inhibitors targeting coronavirus main proteases","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.molstruc.2021.131124_bib0044","first-page":"1","article-title":"An in-silico analysis of ivermectin interaction with potential SARS-CoV-2 targets and host nuclear importin \u03b1","author":"Azam","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molstruc.2021.131124_bib0045","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejmech.2012.10.024","article-title":"Application of a post-docking procedure based on MM-PBSA and MM-GBSA on single and multiple protein conformations","volume":"58","author":"Sgobba","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.molstruc.2021.131124_bib0046","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"issue":"7","key":"10.1016\/j.molstruc.2021.131124_bib0047","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/antibiotics10070856","article-title":"Elucidation of teicoplanin interactions with drug targets related to COVID-19","volume":"10","author":"Azam","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.molstruc.2021.131124_bib0048","first-page":"37","article-title":"Molecular dynamics simulations: advances and applications","volume":"8","author":"Hospital","year":"2015","journal-title":"Adv. Appl. Bioinform. Chem."},{"key":"10.1016\/j.molstruc.2021.131124_bib0049","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.molstruc.2021.131124_bib0050","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1021\/acs.jcim.0c00546","article-title":"Structure-based virtual screening to discover potential lead molecules for the SARS-CoV-2 main protease","volume":"60","author":"Gahlawat","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.molstruc.2021.131124_bib0051","first-page":"1","article-title":"Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings","author":"Avti","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.molstruc.2021.131124_bib0052","doi-asserted-by":"crossref","first-page":"40867","DOI":"10.1039\/D0RA09010G","article-title":"Accelerating the repurposing of FDA-approved drugs against coronavirus disease-19 (COVID-19)","volume":"10","author":"De Vita","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.molstruc.2021.131124_bib0053","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jiph.2021.01.016","article-title":"Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents","volume":"14","author":"Ahmed","year":"2021","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.molstruc.2021.131124_bib0054","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3389\/fchem.2020.628609","article-title":"In silico analysis revealed potential anti-SARS-CoV-2 main protease activity by the zonulin inhibitor larazotide acetate","volume":"8","author":"Di Micco","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.molstruc.2021.131124_bib0055","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1021\/acs.jproteome.0c00383","article-title":"In silico drug repurposing for SARS-CoV-2 main proteinase and spike proteins","volume":"19","author":"Maffucci","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.molstruc.2021.131124_bib0056","doi-asserted-by":"crossref","first-page":"10027","DOI":"10.1039\/D0RA10674G","article-title":"Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study","volume":"11","author":"Elmaaty","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.molstruc.2021.131124_bib0057","doi-asserted-by":"crossref","DOI":"10.1007\/s11030-021-10214-6","article-title":"Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach","author":"Bhowmick","year":"2021","journal-title":"Mol. Divers."},{"key":"10.1016\/j.molstruc.2021.131124_bib0058","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/03639045.2021.1934857","article-title":"Reckoning \u03b3-glutamyl-S-allylcysteine as a potential main protease (mpro) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation","volume":"47","author":"Parashar","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.molstruc.2021.131124_bib0059","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/bib\/bbaa382","article-title":"Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro","volume":"22","author":"Bharadwaj","year":"2021","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.molstruc.2021.131124_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.107904","article-title":"Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study","volume":"105","author":"Ibrahim","year":"2021","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.molstruc.2021.131124_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104568","article-title":"Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation","volume":"135","author":"Prajapati","year":"2021","journal-title":"Comput. Biol. Med."}],"container-title":["Journal of Molecular Structure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022286021012540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022286021012540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T23:50:08Z","timestamp":1758325808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022286021012540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":61,"alternative-id":["S0022286021012540"],"URL":"https:\/\/doi.org\/10.1016\/j.molstruc.2021.131124","relation":{},"ISSN":["0022-2860"],"issn-type":[{"value":"0022-2860","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting SARS-CoV-2 main protease by teicoplanin: A mechanistic insight by docking, MM\/GBSA and molecular dynamics simulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Structure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molstruc.2021.131124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"131124"}}